GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SRTS · Jun 30, 2026

Sensus Healthcare, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration

State dimensions

Filing0001753926-26-001508General Corporate
Capex intensity28thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.35% · OPTIONAL · VALID

Operating cash generation6thOwn-history percentile · N=18
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-136.81% · OPTIONAL · VALID

Revenue growth0thOwn-history percentile · N=14
Evidence method

Yoy · gp.fundamentals.revenue

-68.69% · CORE · VALID

Inventory pressure100thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

806.07% · OPTIONAL · VALID

Gross margin6thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.gross_margin

33.58% · CORE · VALID

Operating margin0thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.operating_margin

-138.86% · CORE · VALID

R&D intensity100thOwn-history percentile · N=18
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

48.43% · OPTIONAL · VALID

SBC intensity94thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

3.06% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History19 statesSelf-history eligible
Dec 31, 20210/7 normalizedLevel 3Mar 31, 20220/7 normalizedLevel 3Jun 30, 20220/7 normalizedLevel 3Sep 30, 20220/7 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/8 normalizedLevel 3Dec 31, 20237/8 normalizedLevel 3Mar 31, 20247/8 normalizedLevel 3Jun 30, 20247/8 normalizedLevel 3Sep 30, 20247/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Capex Intensity Increased
Previous
0.09%
Current
0.35%
Delta
0.26%
Cash Generation Decreased
Previous
-110.58%
Current
-136.81%
Delta
-26.23%
Growth Decreased
Previous
-59.32%
Current
-68.69%
Delta
-9.37%
Inventory Pressure Increased
Previous
486.15%
Current
806.07%
Delta
319.92%
Margin Increased
Previous
29.20%
Current
33.58%
Delta
4.38%
Profitability Decreased
Previous
-128.40%
Current
-138.86%
Delta
-10.46%
R And D Intensity Increased
Previous
46.85%
Current
48.43%
Delta
1.58%
Sbc Intensity Increased
Previous
2.06%
Current
3.06%
Delta
0.99%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Mar 31, 2026
Similarity
93%
Compared
8 dimensions
Coverage
100%
Growth 15.4 · Margin 5.6 · Profitability 0.0 · Sbc Intensity 0.3 · Capex Intensity 10.1 · Cash Generation 0.3 · R And D Intensity 0.0 · Inventory Pressure 0.0
Mar 31, 2025
Similarity
73%
Compared
8 dimensions
Coverage
100%
Growth 44.4 · Margin 9.8 · Profitability 15.4 · Sbc Intensity 25.2 · Capex Intensity 20.1 · Cash Generation 9.8 · R And D Intensity 7.7 · Inventory Pressure 46.2
Dec 31, 2023
Similarity
64%
Compared
7 dimensions
Coverage
88%
Margin 19.4 · Profitability 37.5 · Sbc Intensity 31.9 · Capex Intensity 59.7 · Cash Generation 6.9 · R And D Intensity 37.5 · Inventory Pressure 37.5
Sep 30, 2025
Similarity
57%
Compared
8 dimensions
Coverage
100%
Growth 36.4 · Margin 5.6 · Profitability 13.3 · Sbc Intensity 87.8 · Capex Intensity 21.1 · Cash Generation 67.8 · R And D Intensity 20.0 · Inventory Pressure 13.3
Jun 30, 2024
Similarity
39%
Compared
7 dimensions
Coverage
88%
Margin 34.4 · Profitability 50.0 · Sbc Intensity 94.4 · Capex Intensity 27.8 · Cash Generation 94.4 · R And D Intensity 50.0 · Inventory Pressure 30.0
Research Graph

Related governed research

Analogous To · SRTS state analogue 2 →Analogous To · SRTS state analogue 4 →Compared To · Surgical & Medical Instruments & Apparatus peers →Analogous To · SRTS state analogue 5 →Analogous To · SRTS state analogue 3 →Analogous To · SRTS state analogue 1 →Transitioned To · SRTS Fundamental State →Transitioned To · SRTS CAPEX_INTENSITY_INCREASED →Transitioned To · SRTS CASH_GENERATION_DECREASED →Transitioned To · SRTS GROWTH_DECREASED →Transitioned To · SRTS INVENTORY_PRESSURE_INCREASED →Transitioned To · SRTS MARGIN_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.